chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ADMINISTRATION OF VACCINE FROM PUNCTURED VIAL AFTER 6 HOURS; This spontaneous report received from a health care professional concerned a 21 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 07-MAR-2022) dose was not reported, administered on 03-DEC-2021 15:30 for prophylactic vaccination. No concomitant medications were reported.  On 03-DEC-2021, the patient experienced administration of vaccine from punctured vial to the patient after 6 hours. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of vaccine from punctured vial to the patient after 6 hours was not reported. This report was non-serious.
I developed a rash on my left arm on the injection site. It had red dots and I started using some ointment cream. It was irritated on my shoulder. The rash is still there to this day. It has went down some.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 19-AUG-2014, the patient was vaccinated with the first dose of ZOSTAVAX (0.65 ml, subcutaneously; lot # and expiration date were not reported). In July 2016, the patient was vaccinated with the second dose of ZOSTAVAX (0.65 ml, subcutaneously; lot # and expiration date were not reported). No adverse effects were reported. Additional information has been requested.
Large, red hives on face, chest and arms.  No breathing difficulties.  Administered Benadryl 25mg IM per emergency standing orders.  Hives went away within 15-20 minutes (we held patient to ensure response). Attempted to call Mom later in the week to follow-up, but no return phone call.  Unsure if child saw Dr. after the incident or if anything further occurred, at this time.
Allergic urticaria and all over body including the upper lip. Patient was given KENALOG 40mg IM and BENADRYL 25mg IM. She is also to take BENADRYL OTC. Patient waited 15mns post injection and had no adverse reactions.
CEREBRAL INFARCTION DUE TO THROMBOSIS OF RIGHT MIDDLE CEREBRAL ARTERY  life threatening event hospital admission ICU admission left hemiparesis patient survived with permanent disability
Swollen lymph node in left armpit area; Muscle pain on opposite side of arm where injection site was; This is a spontaneous report from a non-contactable consumer, the patient. A 17-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 29Apr2021 at 14:45 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. The patient did not take any concomitant medications. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021, the patient experienced swollen lymph node in left armpit area, muscle pain on opposite side of arm where the injection site was. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph node in left armpit area and muscle pain on opposite side of arm where the injection site was resolving at the time of the report.  No follow-up attempts are possible. No further information is expected.
get sick around; Initial information was received on 18-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non healthcare professional.  This case involves a patient with unknown demographics who get sick around after being vaccinated with Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza vaccine (produced by unknown manufacturer) (with unknown strength, dose, route, administration site, lot number and expiration date) for Flu vaccination.  On an unknown date the patient get sick around (illness) (unknown latency) following the administration of Influenza vaccine.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.
Muscle aches, with mild fever, headache, & chills lasting 2 days.  Developed rash over belly, chest, and arms after 1 day, which lasted for 2 days.
continuous rash; itching; burning since second vaccine; allergy to chemical; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient (not pregnant) received the second dose of BNT162B2 via an unspecified route of administration on the left arm on 23Mar2021 at 13:00 (Lot Number: Unknown) at the age of 64-year-old as single dose for COVID-19 immunization. Medical history included hypothyroidism, PTSD, depression, latex allergy and penicillin allergy. The patient was not COVID prior vaccination. The patient performed Covid test (Nasal Swab) post vaccination on 17Jul2021 and result was negative. Concomitant medications included levothyroxine sodium, celecoxib (CELEXA [CELECOXIB]) and cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]). The patient previously received the first dose of BNT162B2 via an unspecified route of administration on the left arm on an unspecified date at 13:00 (Lot Number: Unknown) as single dose for COVID-19 immunization. On 24Mar2021 at 01:00 AM, the patient experienced continuous rash, cyclical, itching, and burning since second vaccine. Dermatology biopsies indicate allergy to chemical. The events resulted in emergency room visit and physician office visit. No treatment was received. The outcome of events was not recovered.  The lot number for BNT162B2, was not provided and will be requested during follow up.
Face was on fire/ Chin burning; This is spontaneous report received from a contactable consumer (patient mother reported for her daughter). A 13-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 18May2021 as dose 1, single (at the age 13-years-old) for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Mother had 3 teenagers. 2 teens got the Covid vaccine last Tuesday (18May2021). The 16-year-old and 13-year-old both had substantial side effects. She did not seem to be hearing about them. She did not make the connection to the vaccine until her daughter had the same symptoms the night of her vaccine. They both had the same effects.  Her daughter experienced it even worse than her son. She had 3 teenagers. One is 16, and he got the vaccine approximately 2 weeks ago. The other 2 teens got the vaccine last Tuesday (18May2021). The 16-year-old and 13-year-old both had substantial side effects. She did not seem to be hearing about them. She was concerned about whether they should get the second dose based on their reaction. She asked what Pfizer recommended. She was a social worker. Her son had severe allergies, and they knew that when he went in there. They were watching him. Upon getting it, 15 minutes later his chin was burning. It was not significant and did not get any worse. Then for the next 4 days his face was on fire to the point where he could not even use soap or moisturize because it was really painful. She did not make the connection until her daughter had the same symptoms the night of her vaccine on 18May2021. They both had the same effects. Her son had his first dose of the vaccine on 12May2021. The burning in his chin went away. She was not sure when it went away. It did not last that long. His face started the night he got the vaccine. It lasted for about 4 days. It has totally gone away. She was just wondering, she was pretty savvy in terms of reading and she has not seen this reaction publicized. Both her 16-year-old and her 13-year-old were in the later stage of puberty. That was the only other correlation between her two kids that she can imagine. They did not have the vaccine on the same day, so it was not the batch. Her daughter experienced it even worse than her son. She hoped Pfizer is figuring all of this out. The adverse event did not result emergency room or physician office visit. The outcome of the events was unknown.   Information on Lot/Batch number was available. Additional information has been requested.
Tongue and mouth swelling - went to ER and received steroids po and Rx for steroid taper.
One reaction is it has exuberated my vitiligo and have lost a lot of pigmentation. It started at my feet as pins and needles in Jan after the second vaccine daily.  I or 2 times a day I have vibrations, muscle spasms, nerves and moves, after Feb. 12 sever consistently increase  lasting it feels like a shock, and tighting chest and pressure, it can start at my arms and move to hands, mostly accrues from my mid section up.  I loose muscle control during at it's worse. It can last up to 1.5 before returning to normal but can still feel neurological movement all the time.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Dec2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 37 years for covid-19 immunisation. The patient's relevant medical history included: "ITP" (unspecified if ongoing), notes: ITP; "Anemia" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 with antiviral (Pfizer) treatment start date was 11Jan2023.  Clinical information : It was reported as, No known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Arm hurts; When she touched it it hurts.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Apr2021 09:00 (Lot number: ER8731) at the age of 29 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, Lot No: EP6955, Expiry date: unknown, Left arm), administration date: 26Mar2021, when the patient was 29 years old, for Covid-19 immunization, reaction(s): "Arm hurts". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Arm hurts"; HYPERAESTHESIA (non-serious), outcome "unknown", described as "When she touched it it hurts." Additional information: The patient took Pfizer COVID vaccine as her decision because of her girl. The Vaccination Facility Type: a place where people were getting it in, a big building. There was no History of all previous immunization with the Pfizer vaccine considered as suspect, no additional Vaccines Administered on Same Date of the Pfizer Suspect. The events did not cause healthcare professional office/ Emergency room. Patient received no other vaccines within 4 weeks PRIOR to the COVID-19 vaccine. The patient did not have any AE(s) following prior vaccinations and no Medical History (including any illness at time of vaccination). The patient did not have diagnosed allergies, compromised immune status, respiratory illness, genetic/chromosomal abnormalities, endocrine abnormalities (including diabetes). The patient did not have any Family Medical History Relevant to AE(s) and Relevant Tests.  No follow-up attempts are possible. No further information is expected.
Pt recvd vax 17NOV92 & on 5DEC92 nasophyringal asperate was pos for resp syncytical virus; 9DEC92 pt devel a fever & a rash; was not hospitalized;
Soreness, stiffness at injection area radiating to upper shoulder, neck and collarbone area. Extreme fatigue, symptoms similar to fighting minor infection or virus, i.e. muscle aches.
Patient seated in chair. Patient visibly nervous prior to vaccine, squeezing on stress ball to help relax. Gardasil booster given in left deltoid. Vaccine given and patient stated, "I did it!" and then stated she felt dizzy. Nurse had patient remain seated and as nurse was explaining possible syncope after vaccines patient slumped over onto nurse. Nurse attempted to lift patients head while calling her name and patient did not respond. Patients mouth clamped shut, extremities shot out rigid,  and started jerky movements (lasted ~7 seconds). Nurse instructed mother to open the door and call for help while nurse gently moved patient to a supine position on the floor. Once placed on cool tile floor patient immediately opened her mouth and took a breath, Jerky movements stopped, patients extremities softened and patient opened her eyes with confused look. Patient able to respond to nurses questions appropriately. Nurse explained to patient what was going on and asked her to remain in supine position on the floor. Dr. entered the room and examined patient. Nurse applied wet cloth to patients neck and patient reported that helped. Patient denies any continued dizziness or other symptoms. Patient moved to sitting position without issue. After examined Patient moved up to chair without issue. Mother reports patient had just eaten breakfast, no known history of seizure activity or issues with vaccines other than "she usually cries due to extreme nervousness". Limited family history available as patient is adopted. Vitals taken and stable. Patient continued to state she feels fine and was able to walk out of clinic without issue.
ACUTE RESPIRATORY FAILURE 2/17/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Dizziness, NauseaVomiting, HYPERtension, Tachycardia, Flush Narrative:
Information has been received from a consumer concerning her 75 year old mother with cholesterol disease and no drug allergies who on 13-SEP-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (LOT# "0741Y"). There was no concomitant medication. Over the weekend (on approximately 06-JUN-2010) the patient experienced shingles. She thought initially that it was indigestion or heart problems. X-ray and blood work were done without result provided. Unspecified medical attention was sought. At this time of reporting, the patient has not recovered. Additional information has been requested.
Fever; Chills; Nausea; Feeling Sick to her stomach; This case was reported by a consumer via call center representative and described the occurrence of fever in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd September 2019 12:00, the patient received the 1st dose of Shingrix. On 24th September 2019, 1 days after receiving Shingrix, the patient experienced fever, chills, nausea and upset stomach. On an unknown date, the outcome of the fever, chills, nausea and upset stomach were unknown.   It was unknown if the reporter considered the fever, chills, nausea and upset stomach to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix at 12:00 pm and had fever, chills, and nausea.  She had to end the call because she was feeling sick to her stomach. The reporter unable to obtain additional details because the reporter felt sick to her stomach and ended the call.
Patient had a tactile fever for 3 days after the vaccine and then developed a blanching, macular rash on the face, torso, arms 5 days later.
Patient was administered a dose of Janssen on 9/22/2021 that expired on 9/21/2021
11 years old was administered with Infanrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old female patient who received DTPa (Infanrix) (batch number 4L9E4, expiry date 7th February 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 27th September 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 27th September 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   It was unknown if the reporter considered the inappropriate age at vaccine administration to be related to Infanrix and Infanrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse informed that a 11 years old patient was administered with Infanrix by mistake, which led to inappropriate age at vaccine administration. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021204762:same reporter - FU1 - case deleted.
covid arm, sore, swollen, dark red, rt arm, headache, dizziness nausea
Covid; Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:.  A male patient received BNT162b2 (BNT162B2), in Jun2021 as dose number (unknown), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant), outcome "unknown" and all described as "Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive.  Additional information: We both my husband and I got our vaccines a year ago in Jun and both have Covid. What compensation am I entitled too? He may be entering the hospital as of today. The lot number for the vaccine , BNT162B2 was not provided and will be requested during follow-up.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200696967 same reporter/drug/event, different pt
Patient describes a chief complaint of nausea and symptoms of localized erythema the size of a quarter, swelling and warmth at injection site that began 12 hours after receiving the vaccination. The patient denies any treatment for her complaint of symptoms, but stated a similar reaction when she received a FLU vaccine in 2009.
Information has been received from a public health nurse concerning a pt who on 08/11/99 was vaccinated with a dose of varicella virus vaccine live (Lot # 629612/0284J).  Subsequently, the pt developed chickenpox breakthrough. It was noted that this case was part of 4 cases of chickenpox breakthrough one of which was "mild" and the other three were "regular chickenpox". Unspecified medical attention was sought. There was no product quality complaint involved.  The reporter also mentioned three other pt's who developed chickenpox breakthrough and experienced similar reactions (WAES # 0403USA00650, 0403USA01868, 0403USA01869).  Additional information has been requested.
Left arm blew up puffy. Red splotch size of grapefruit approx 8 in. wrapped around tricep. Burning sensation. Went to ER directly at time of noticing. Generalized vaccinia.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and unknown gender. Pertinent medical history and drug reactions/allergies were not reported. On unknown dates the patients received doses of improperly stored ROTATEQ (dose, lot# and expiration date were not reported) orally. Concomitant drug was not reported. No adverse effects were reported. It was unknown whether the patients sought medical attention. Additional information has been requested.
strange adverse event post vaccination; feeling tired; Vomiting; a tingling burning sensation underarm and whole body like it's cold then dipped in hot water; a tingling burning sensation underarm and whole body like it's cold then dipped in hot water; sunburn looking rash on chest; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (strange adverse event post vaccination), BURNING SENSATION (a tingling burning sensation underarm and whole body like it's cold then dipped in hot water), PARAESTHESIA (a tingling burning sensation underarm and whole body like it's cold then dipped in hot water), RASH ERYTHEMATOUS (sunburn looking rash on chest) and FATIGUE (feeling tired) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced BURNING SENSATION (a tingling burning sensation underarm and whole body like it's cold then dipped in hot water), PARAESTHESIA (a tingling burning sensation underarm and whole body like it's cold then dipped in hot water) and RASH ERYTHEMATOUS (sunburn looking rash on chest). On an unknown date, the patient experienced VACCINATION COMPLICATION (strange adverse event post vaccination), FATIGUE (feeling tired) and VOMITING (Vomiting). At the time of the report, VACCINATION COMPLICATION (strange adverse event post vaccination), BURNING SENSATION (a tingling burning sensation underarm and whole body like it's cold then dipped in hot water), PARAESTHESIA (a tingling burning sensation underarm and whole body like it's cold then dipped in hot water), RASH ERYTHEMATOUS (sunburn looking rash on chest), FATIGUE (feeling tired) and VOMITING (Vomiting) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products included Birth control for an unknown indication. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Non significant FU added. Updated email address
Severe headache , muscle aches , nausea , dizziness , and fast heart rate.
Varicella- Information has been received from a physician concerning an 8 year old white male student with no past medical history who on 08 Mar 1996 was vaccinated with the first dose of vericella virus vaccine live SC in the left thigh (lot 612212/0753B).  There was no concomitant medication.  On 15 May 2000 the patient experienced breakthrough chickenpox with 20 or more pox and was alightly febrile.  Medical attention was sought.  On 25 May 2000, the patient recovered. The patient's sister had a similar experienced following vaccination with varicella virus vaccine live (waes 00060311.
pt adm to hosp via ER w/erythematous, swelling in the inj site which worsened & swelling grew all the way down to lt hand 1 day p/vax;local erythematous, swelling & pain @ inj site;warmth;limitation of motion;poss hypersensitivity rxn;